These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8405332)

  • 21. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Elmaagacli AH; Beelen DW; Schaefer UW
    Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of interferon in the treatment of chronic myelogenous leukemia in chronic phase.
    Guilhot F
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S39-46. PubMed ID: 8177714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon therapy for Ph1-positive chronic myelogenous leukaemia patients relapsing after T-cell depleted allogeneic bone marrow transplantation.
    Arcese W; Mauro FR; Screnci M; Alimena G; Lo Coco F; Iori AP; de Cuia MR; Fazi P; Montefusco E; Mandelli F
    Eur J Cancer; 1991; 27 Suppl 4():S28-30. PubMed ID: 1799471
    [No Abstract]   [Full Text] [Related]  

  • 24. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group.
    Guilhot F; Chastang C; Michallet M; Guerci A; Harousseau JL; Maloisel F; Bouabdallah R; Guyotat D; Cheron N; Nicolini F; Abgrall JF; Tanzer J
    N Engl J Med; 1997 Jul; 337(4):223-9. PubMed ID: 9227927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematological and cytogenetic response of interferon alpha 2b alone and combined interferon alpha plus cytarabine as a first-line treatment in chronic myeloid leukemia.
    Tóthová E; Fricová M; Kafková A; Stecová N; Guman T; Raffac S; Hlebasková M
    Neoplasma; 2000; 47(2):125-8. PubMed ID: 10985480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
    Bergsagel DE; Messner H
    Br J Cancer; 1990 Jun; 61(6):895-8. PubMed ID: 2372493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of a Ki-1-positive anaplastic large-cell lymphoma in a patient with Ph' positive chronic myelogenous leukemia successfully treated by alpha-interferon.
    Montefusco E; Lo Coco F; Burgio VL; Rondinelli B; Di Giorgio G; Mancini M; Diverio D; Andriani A; Avvisati G; Alimena G
    Leukemia; 1993 Nov; 7(11):1896-9. PubMed ID: 8231259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study.
    Kühr T; Eisterer W; Apfelbeck U; Linkesch W; Bechter O; Zabernigg A; Geissler K; Barbieri G; Duba C; Gastl G; Thaler J
    Leuk Res; 2000 Jul; 24(7):583-7. PubMed ID: 10867132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon alfa therapy in an infant with juvenile chronic myelogenous leukemia.
    Toraldo R; Vetrano F; Pistoia V; Tolone C; Canino G; D'Avanzo M; Iafusco F
    Pediatr Hematol Oncol; 1995; 12(2):189-94. PubMed ID: 7626389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia.
    Freund M; Hild F; Grote-Metke A; Nowak R; Otremba B; Wörmann B; Koch O; Dohmen M; Kleine HD; Link H
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):11-3. PubMed ID: 8235696
    [No Abstract]   [Full Text] [Related]  

  • 31. Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alpha.
    Carella AM; Simonsson B; Link H; Lennard A; Boogaerts M; Gorin NC; Tomas-Martinez JF; Dabouz-Harrouche F; Gautier L; Badri N
    Br J Haematol; 1998 Apr; 101(1):111-8. PubMed ID: 9576191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy.
    Dewald GW; Wyatt WA; Silver RT
    Leuk Lymphoma; 1999 Aug; 34(5-6):481-91. PubMed ID: 10492071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term treatment of chronic myelogenous leukemia with different interferons: results from three studies.
    Niederle N; Kloke O; Wandl UB; Becher R; Moritz T; Opalka B
    Leuk Lymphoma; 1993 Jan; 9(1-2):111-9. PubMed ID: 8477190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged survival and probable cure in chronic myelogenous leukemia.
    Gabor EP
    Am J Hematol; 1995 Oct; 50(2):149. PubMed ID: 7572999
    [No Abstract]   [Full Text] [Related]  

  • 35. Recombinant human interferon (IFN) alpha-2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti-interferon antibodies.
    Freund M; von Wussow P; Diedrich H; Eisert R; Link H; Wilke H; Buchholz F; LeBlanc S; Fonatsch C; Deicher H
    Br J Haematol; 1989 Jul; 72(3):350-6. PubMed ID: 2765403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interferon in the treatment of Philadelphia-positive chronic myeloid leukemia].
    Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Inverardi D; Bernasconi P; Mancini M; Donti E; Senatore M
    Haematologica; 1990; 75 Suppl 4():33-40. PubMed ID: 1705912
    [No Abstract]   [Full Text] [Related]  

  • 37. Response to alpha-interferon in children with Philadelphia chromosome-positive chronic myelocytic leukemia.
    Dow LW; Raimondi SC; Culbert SJ; Ochs J; Kennedy W; Pinkel DP
    Cancer; 1991 Oct; 68(8):1678-84. PubMed ID: 1833044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy of chronic myelogenous leukemia.
    Talpaz M; Kantarjian H; McCredie K; Trujillo J; Keating M; Gutterman JU
    Cancer; 1987 Feb; 59(3 Suppl):664-7. PubMed ID: 10822467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic myelogenous leukemia: does interferon alpha prolong life?
    Hehlmann R
    Leukemia; 1996 Feb; 10(2):193-6. PubMed ID: 8637225
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon alfa-2b and cytarabine in chronic myelogenous leukemia.
    Patel T; Roychowdhury DF
    N Engl J Med; 1997 Nov; 337(22):1634-5. PubMed ID: 9411231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.